vs
Globe Life（GL）与MAXIMUS, INC.（MMS）财务数据对比。点击上方公司名可切换其他公司
Globe Life的季度营收约是MAXIMUS, INC.的1.2倍（$1.5B vs $1.3B），MAXIMUS, INC.净利率更高（30.2% vs 17.5%，领先12.7%），Globe Life同比增速更快（3.6% vs -2.8%），MAXIMUS, INC.自由现金流更多（$450.0M vs $330.1M），过去两年Globe Life的营收复合增速更高（3.6% vs -0.3%）
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
MAXIMUS是美国一家政府服务企业，业务覆盖美国、加拿大、英国等国家，为医疗补助、联邦医疗保险、医改、就业帮扶、学生贷款服务等各类政府项目提供行政及配套服务。公司总部位于弗吉尼亚州泰森斯，现有员工3.96万名，2024财年营收达53亿美元。
GL vs MMS — 直观对比
营收规模更大
GL
是对方的1.2倍
$1.3B
营收增速更快
GL
高出6.4%
-2.8%
净利率更高
MMS
高出12.7%
17.5%
自由现金流更多
MMS
多$119.9M
$330.1M
两年增速更快
GL
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.3B |
| 净利润 | $266.1M | $394.0M |
| 毛利率 | — | 26.2% |
| 营业利润率 | 21.7% | 11.4% |
| 净利率 | 17.5% | 30.2% |
| 营收同比 | 3.6% | -2.8% |
| 净利润同比 | 4.3% | -4.1% |
| 每股收益（稀释后） | $3.28 | $7.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLMMS
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.4B | $1.3B |
净利润GLMMS
| Q1 26 | — | $394.0M | ||
| Q4 25 | $266.1M | $93.9M | ||
| Q3 25 | $387.8M | $75.3M | ||
| Q2 25 | $252.7M | $106.0M | ||
| Q1 25 | $254.6M | $96.6M | ||
| Q4 24 | $255.2M | $41.2M | ||
| Q3 24 | $303.0M | $72.5M | ||
| Q2 24 | $258.4M | $89.8M |
毛利率GLMMS
| Q1 26 | — | 26.2% | ||
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 25.3% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | 26.1% | 22.9% | ||
| Q2 24 | 23.3% | 25.3% |
营业利润率GLMMS
| Q1 26 | — | 11.4% | ||
| Q4 25 | 21.7% | 10.9% | ||
| Q3 25 | 31.5% | 9.3% | ||
| Q2 25 | 21.2% | 12.3% | ||
| Q1 25 | 21.4% | 11.2% | ||
| Q4 24 | 21.3% | 6.2% | ||
| Q3 24 | 26.3% | 8.5% | ||
| Q2 24 | 23.5% | 10.8% |
净利率GLMMS
| Q1 26 | — | 30.2% | ||
| Q4 25 | 17.5% | 7.0% | ||
| Q3 25 | 25.6% | 5.7% | ||
| Q2 25 | 17.1% | 7.9% | ||
| Q1 25 | 17.2% | 7.1% | ||
| Q4 24 | 17.4% | 2.9% | ||
| Q3 24 | 20.8% | 5.5% | ||
| Q2 24 | 17.9% | 6.8% |
每股收益（稀释后）GLMMS
| Q1 26 | — | $7.27 | ||
| Q4 25 | $3.28 | $1.70 | ||
| Q3 25 | $4.73 | $1.27 | ||
| Q2 25 | $3.05 | $1.86 | ||
| Q1 25 | $3.01 | $1.69 | ||
| Q4 24 | $3.00 | $0.69 | ||
| Q3 24 | $3.44 | $1.18 | ||
| Q2 24 | $2.83 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $314.7M | $157.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $6.0B | $1.7B |
| 总资产 | $30.8B | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLMMS
| Q1 26 | — | $157.5M | ||
| Q4 25 | $314.7M | $137.6M | ||
| Q3 25 | $62.8M | $222.4M | ||
| Q2 25 | $116.7M | $59.8M | ||
| Q1 25 | $134.1M | $108.1M | ||
| Q4 24 | $85.0M | $72.7M | ||
| Q3 24 | $100.5M | $183.1M | ||
| Q2 24 | $100.6M | $102.8M |
股东权益GLMMS
| Q1 26 | — | $1.7B | ||
| Q4 25 | $6.0B | $1.7B | ||
| Q3 25 | $5.7B | $1.7B | ||
| Q2 25 | $5.4B | $1.8B | ||
| Q1 25 | $5.4B | $1.7B | ||
| Q4 24 | $5.3B | $1.6B | ||
| Q3 24 | $4.6B | $1.8B | ||
| Q2 24 | $5.2B | $1.8B |
总资产GLMMS
| Q1 26 | — | $4.2B | ||
| Q4 25 | $30.8B | $4.2B | ||
| Q3 25 | $30.5B | $4.1B | ||
| Q2 25 | $29.8B | $4.5B | ||
| Q1 25 | $29.7B | $4.2B | ||
| Q4 24 | $29.1B | $4.1B | ||
| Q3 24 | $29.6B | $4.1B | ||
| Q2 24 | $28.3B | $4.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $350.6M | — |
| 自由现金流经营现金流 - 资本支出 | $330.1M | $450.0M |
| 自由现金流率自由现金流/营收 | 21.7% | 34.5% |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 1.32× | — |
| 过去12个月自由现金流最近4个季度 | $1.3B | $643.0M |
8季度趋势，按日历期对齐
经营现金流GLMMS
| Q1 26 | — | — | ||
| Q4 25 | $350.6M | $-244.4M | ||
| Q3 25 | $306.0M | $649.4M | ||
| Q2 25 | $307.9M | $-182.7M | ||
| Q1 25 | $431.9M | $42.7M | ||
| Q4 24 | $336.9M | $-80.0M | ||
| Q3 24 | $340.6M | $163.8M | ||
| Q2 24 | $374.1M | $199.3M |
自由现金流GLMMS
| Q1 26 | — | $450.0M | ||
| Q4 25 | $330.1M | $-250.7M | ||
| Q3 25 | $208.7M | $641.8M | ||
| Q2 25 | $295.0M | $-198.2M | ||
| Q1 25 | $420.1M | $25.5M | ||
| Q4 24 | $321.9M | $-103.0M | ||
| Q3 24 | $311.3M | $131.9M | ||
| Q2 24 | $356.5M | $164.6M |
自由现金流率GLMMS
| Q1 26 | — | 34.5% | ||
| Q4 25 | 21.7% | -18.6% | ||
| Q3 25 | 13.8% | 48.7% | ||
| Q2 25 | 19.9% | -14.7% | ||
| Q1 25 | 28.4% | 1.9% | ||
| Q4 24 | 22.0% | -7.3% | ||
| Q3 24 | 21.4% | 10.0% | ||
| Q2 24 | 24.8% | 12.5% |
资本支出强度GLMMS
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 0.5% | ||
| Q3 25 | 6.4% | 0.6% | ||
| Q2 25 | 0.9% | 1.1% | ||
| Q1 25 | 0.8% | 1.3% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 1.2% | 2.6% |
现金转化率GLMMS
| Q1 26 | — | — | ||
| Q4 25 | 1.32× | -2.60× | ||
| Q3 25 | 0.79× | 8.63× | ||
| Q2 25 | 1.22× | -1.72× | ||
| Q1 25 | 1.70× | 0.44× | ||
| Q4 24 | 1.32× | -1.94× | ||
| Q3 24 | 1.12× | 2.26× | ||
| Q2 24 | 1.45× | 2.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GL
| Life Segment | $849.6M | 56% |
| Health Segment | $392.3M | 26% |
| Investment Segment | $281.4M | 19% |
MMS
暂无分部数据
